Medical Support Products is pleased to announce that the CoSense ETCO Monitor is now available in PA and NJ.
CoSense is a portable, non-invasive device that rapidly and accurately measures carbon monoxide in the exhaled breath of newborns. The measurement of carbon monoxide is the gold standard for measuring hemolysis, a condition that, if left untreated, may lead to elevated levels of bilirubin in the blood and a range of neurodevelopmental disorders.1
Approximately 60% of healthy infants and 80% of premature infants have jaundice during the neonatal period.2,3 It has been widely reported that the presence of hemolysis in a newborn with jaundice is a predictor of adverse neurodevelopmental outcomes such as low IQ, auditory abnormalities and kernicterus. With ETCO data, physicians may be able to more quickly identify and manage newborns with jaundice who are at risk. The American Academy of Pediatrics Clinical Practice Guidelines already recommend the use of ETCO monitoring in infants with jaundice.4
CoSense is indicated for the monitoring of CO in exhaled breath. To administer the test, a clinician places the nasal cannula onto the patient and connects the other end into the CoSense device. Once a test is initiated, the CoSense monitor will identify a valid breath sample and measures the amount of CO in the breath sample. The CoSense monitor also measures and corrects for CO in the ambient environment.